Neuroblastoma typically affects children under five and can develop before birth. It is the second most common solid tumour in children after brain tumours. Symptoms are often hard to diagnose in the early stages. Many children present with general symptoms such as aches, pains, reduced appetite, or sweating, and may seem generally unwell.

Children at high-risk may need extremely intensive treatment that can last for years. Despite enduring this gruelling treatment, for almost half of these children the treatment fails and the cancer comes back. Tragically many of these children go on to lose their lives at a young age.

We have funded research into neuroblastoma to help better understand the condition, as well as develop new treatments for this.